DK0885971T3 - Fremgangsmåde og præparat til kromosomspecifik farvning - Google Patents
Fremgangsmåde og præparat til kromosomspecifik farvningInfo
- Publication number
- DK0885971T3 DK0885971T3 DK98202403T DK98202403T DK0885971T3 DK 0885971 T3 DK0885971 T3 DK 0885971T3 DK 98202403 T DK98202403 T DK 98202403T DK 98202403 T DK98202403 T DK 98202403T DK 0885971 T3 DK0885971 T3 DK 0885971T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- methods
- probes
- cytogenetic
- acid probes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/601—Detection means characterised by use of a special device being a microscope, e.g. atomic force microscopy [AFM]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44466989A | 1989-12-01 | 1989-12-01 | |
US49709890A | 1990-03-20 | 1990-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0885971T3 true DK0885971T3 (da) | 2007-11-12 |
Family
ID=27034011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98202403T DK0885971T3 (da) | 1989-12-01 | 1990-08-08 | Fremgangsmåde og præparat til kromosomspecifik farvning |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP0885971B1 (fr) |
JP (4) | JP3771934B2 (fr) |
KR (1) | KR910012263A (fr) |
AT (2) | ATE176281T1 (fr) |
AU (1) | AU647741B2 (fr) |
DE (2) | DE69032920T4 (fr) |
DK (1) | DK0885971T3 (fr) |
IE (2) | IE902727A1 (fr) |
NZ (1) | NZ234529A (fr) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6475720B1 (en) | 1986-01-16 | 2002-11-05 | The Regents Of The University Of California | Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17 |
US6872817B1 (en) | 1986-01-16 | 2005-03-29 | The Regents Of The Univ. Of California | Method of staining target interphase chromosomal DNA |
US5721098A (en) * | 1986-01-16 | 1998-02-24 | The Regents Of The University Of California | Comparative genomic hybridization |
US6280929B1 (en) | 1986-01-16 | 2001-08-28 | The Regents Of The University Of California | Method of detecting genetic translocations identified with chromosomal abnormalities |
US7115709B1 (en) | 1986-01-16 | 2006-10-03 | The Regents Of The University Of California | Methods of staining target chromosomal DNA employing high complexity nucleic acid probes |
US5447841A (en) | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
US6344315B1 (en) | 1986-01-16 | 2002-02-05 | The Regents Of The University Of California | Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17 |
US5756696A (en) * | 1986-01-16 | 1998-05-26 | Regents Of The University Of California | Compositions for chromosome-specific staining |
DE68928535T2 (de) * | 1988-12-06 | 1998-04-16 | Flinders Technologies Pty Ltd | Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik |
US8592155B2 (en) | 1989-07-19 | 2013-11-26 | The Regents Of The University Of California | Method of detecting genetic deletions identified with chromosomal abnormalities |
AU647741B2 (en) * | 1989-12-01 | 1994-03-31 | Regents Of The University Of California, The | Methods and compositions for chromosome-specific staining |
US5491224A (en) * | 1990-09-20 | 1996-02-13 | Bittner; Michael L. | Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture |
US5789161A (en) * | 1990-09-20 | 1998-08-04 | Amoco Corporation | Methods for genome identification using direct label probe composition |
AU9178491A (en) * | 1990-12-13 | 1992-07-08 | Board Of Regents, The University Of Texas System | In-situ hybridization probes for identification and banding of specific human chromosomes and regions |
US5538869A (en) * | 1990-12-13 | 1996-07-23 | Board Of Regents, The University Of Texas System | In-situ hybridization probes for identification and banding of specific human chromosomes and regions |
US6025126A (en) | 1991-10-28 | 2000-02-15 | Arch Development Corporation | Methods and compositions for the detection of chromosomal aberrations |
GB9204610D0 (en) * | 1992-03-03 | 1992-04-15 | Lynxvale Ltd | Detection of trisomy 21;materials and methods |
JP3645903B2 (ja) | 1992-03-04 | 2005-05-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 比較ゲノムハイブリダイゼーション(cgh) |
US5976790A (en) * | 1992-03-04 | 1999-11-02 | The Regents Of The University Of California | Comparative Genomic Hybridization (CGH) |
US7534567B2 (en) | 1992-03-04 | 2009-05-19 | The Regents Of The University Of California | Detection of nucleic acid sequence differences by comparative genomic hybridization |
EP0635067A1 (fr) * | 1992-04-09 | 1995-01-25 | Ig Laboratories Inc. | Sondes pour detecter les aneuplo dies chromosomiques courantes d'enfants nes vivants |
AU5355594A (en) * | 1992-10-09 | 1994-05-09 | Oncor, Inc. | Methods for the detection of chromosome structural abnormalities by (in situ) hybridization to fixed tissue |
WO1994016104A1 (fr) * | 1993-01-08 | 1994-07-21 | Ctrc Research Foundation | Systeme d'imagerie couleur utilise en biologie moleculaire |
US5597694A (en) * | 1993-10-07 | 1997-01-28 | Massachusetts Institute Of Technology | Interspersed repetitive element-bubble amplification of nucleic acids |
US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
US5814444A (en) * | 1995-06-07 | 1998-09-29 | University Of Washington | Methods for making and using single-chromosome amplfication libraries |
AU3417895A (en) * | 1995-08-25 | 1997-03-19 | Dade International Inc. | Chronic myelogenous leukemia diagnostic assay |
US5892010A (en) * | 1996-07-15 | 1999-04-06 | The Regents Of The University Of California | Genes from the 20Q13 amplicon and their uses |
US5801021A (en) | 1995-10-20 | 1998-09-01 | The Regents Of The University Of California | Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer |
US7049424B2 (en) | 1996-07-15 | 2006-05-23 | The Regents Of The University Of California | Genes from the 20Q13 amplicon and their uses |
US7455964B1 (en) | 1996-07-15 | 2008-11-25 | The Hospital For Sick Children | Genes from the 20q13 amplicon and their uses |
US5776683A (en) * | 1996-07-11 | 1998-07-07 | California Pacific Medical Center | Methods for identifying genes amplified in cancer cells |
EP1783139B8 (fr) | 1996-10-01 | 2009-09-23 | Geron Corporation | Sous-unité catalytique de télomérase humaine |
EP2264427B1 (fr) | 1997-01-31 | 2017-05-03 | Xy, Llc | Dispositif optique avec réflecteur focalisant pour faire converger la radiation sur un débit de particule, et procédé d'analyse associé |
EP0878552A1 (fr) * | 1997-05-13 | 1998-11-18 | Erasmus Universiteit Rotterdam | Détection moléculaire d'aberration chromosomique |
US6149867A (en) | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
EP1092783A4 (fr) * | 1998-02-25 | 2004-11-03 | Sumitomo Electric Industries | Procede de diagnostic du cancer fonde sur la detection d'anomalies chromosomiques |
US6414133B1 (en) | 1998-10-13 | 2002-07-02 | Ventana Medical Systems, Inc. | Multiple fusion probes |
US7208265B1 (en) | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
GB0009784D0 (en) * | 2000-04-20 | 2000-06-07 | Simeg Limited | Methods for clinical diagnosis |
GB0016742D0 (en) * | 2000-07-10 | 2000-08-30 | Simeg Limited | Diagnostic method |
US7083924B2 (en) | 2000-07-10 | 2006-08-01 | Btg International Limited | Diagnostic method for the identification of foetal DNA in a material sample |
US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
BRPI0115792B1 (pt) | 2000-11-29 | 2020-05-05 | Colorado State Univ | sistema para separação de espermatozóides congelados/descongelados em populações portadoras de cromossomo-x e portadoras de cromossomo-y |
WO2002093130A2 (fr) | 2001-05-14 | 2002-11-21 | Cancer Genetics, Inc. | Methodes d'analyse de translocations chromosomiques par hybridation in situ en fluorescence |
JP4595067B2 (ja) | 2002-08-01 | 2010-12-08 | エックスワイ,エルエルシー | 低圧***細胞分離システム |
US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
CA2534394C (fr) | 2002-08-15 | 2013-01-08 | Xy, Inc. | Cytometre a flux haute resolution |
JP2004089046A (ja) * | 2002-08-30 | 2004-03-25 | Fuso Pharmaceutical Industries Ltd | カンジダアルビカンス菌の検出用プローブおよびそれを用いた方法 |
US7169548B2 (en) | 2002-09-13 | 2007-01-30 | Xy, Inc. | Sperm cell processing and preservation systems |
EP2359689B1 (fr) | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Dispositif microfluidique pour la séparation de cellules et usage du dispositif |
ES2918578T3 (es) | 2003-03-28 | 2022-07-19 | Inguran Llc | Aparato y métodos para proporcionar esperma animal clasificado por sexo |
NZ544103A (en) | 2003-05-15 | 2010-10-29 | Xy Llc | Efficient haploid cell sorting for flow cytometer systems |
WO2005079474A2 (fr) | 2004-02-17 | 2005-09-01 | The Regents Of The University Of California | Detection de differences de sequences d'acide nucleique par hybridation genomique comparative |
CA2561519C (fr) | 2004-03-29 | 2017-08-22 | Monsanto Technology Llc | Suspensions de sperme pour insemination |
WO2005111235A2 (fr) * | 2004-05-04 | 2005-11-24 | Dak Denmark A/S | Procedes de detection d'aberrations chromosomiques |
CA2574499C (fr) | 2004-07-22 | 2016-11-29 | Monsanto Technology Llc | Procede pour enrichir une population de spermatozoides |
EP1853735B1 (fr) | 2005-02-18 | 2011-02-09 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Procedes pour detecter l'evolution d'une dysplasie du col uterin bien differenciee |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US20100286232A1 (en) | 2006-03-02 | 2010-11-11 | The Ohio State University | Microrna expression profile associated with pancreatic cancer |
WO2008036851A2 (fr) | 2006-09-20 | 2008-03-27 | Colorado State University Research Fondation | Détection d'inversions chromosomiques |
EP2851091B1 (fr) | 2007-04-13 | 2017-12-27 | Dana-Farber Cancer Institute, Inc. | Procédés de traitement d'un cancer résistant à des agents thérapeutiques ERBB |
US20110110923A1 (en) * | 2008-02-12 | 2011-05-12 | The Brigham And Women's Hospital, Inc. | Fish assay for eml4 and alk fusion in lung cancer |
TWI518325B (zh) | 2010-02-04 | 2016-01-21 | 自治醫科大學 | 對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療 |
DK2609216T3 (en) | 2010-08-24 | 2016-09-12 | Dana Farber Cancer Inst Inc | Methods to predict anti-cancer response |
US9090935B2 (en) | 2010-10-11 | 2015-07-28 | Kromatid, Inc. | Characterization of chromosomal inversions using anti-parallel probes |
KR20140016241A (ko) | 2010-10-25 | 2014-02-07 | 메사추세츠 인스티튜트 오브 테크놀로지 | 상처 치유 메타카리오틱 줄기 세포 및 그 사용방법 |
EP2715345A1 (fr) * | 2011-06-02 | 2014-04-09 | Massachusetts Institute of Technology | Forme intermédiaire de réplication du génome hybride arndb/adn des cellules souches métacaryotes |
EP2721176A2 (fr) | 2011-06-17 | 2014-04-23 | Dana-Farber Cancer Institute, Inc. | Signatures pour prédire la capacité de survie de sujets atteints de syndromes myélodysplasiques |
CA2839210A1 (fr) | 2011-06-17 | 2012-12-20 | Myriad Genetics, Inc. | Methodes et materiaux permettant de determiner un desequilibre allelique |
DK2748192T3 (en) | 2011-08-23 | 2019-02-25 | Found Medicine Inc | KIF5B-RET-FUSION MOLECULES AND APPLICATIONS THEREOF |
US10378060B2 (en) | 2011-10-14 | 2019-08-13 | Dana-Farber Cancer Institute, Inc. | ZNF365/ZFP365 biomarker predictive of anti-cancer response |
ES2759533T5 (es) | 2011-12-21 | 2023-06-22 | Myriad Genetics Inc | Métodos y materiales para evaluar la pérdida de heterocigosidad |
CA3080441A1 (fr) | 2012-02-23 | 2013-09-06 | The Children's Hospital Corporation | Methodes de prediction d'une reponse anticancereuse |
ES2658867T3 (es) | 2012-06-07 | 2018-03-12 | Institut Curie | Métodos para detectar la inactivación de la ruta de recombinación homóloga (BRCA1/2) en tumores humanos |
EP2880448B1 (fr) | 2012-08-03 | 2022-06-29 | Foundation Medicine, Inc. | Papillomavirus humain en tant que prédicteur du pronostic du cancer |
WO2014071358A2 (fr) | 2012-11-05 | 2014-05-08 | Foundation Medicine, Inc. | Nouvelles molécules de fusion de ntrk1 et leurs utilisations |
EP3939614A1 (fr) | 2013-01-18 | 2022-01-19 | Foundation Medicine, Inc. | Méthodes de traitement du cholangiocarcinome |
WO2014160080A1 (fr) | 2013-03-14 | 2014-10-02 | Children's Medical Center Corporation | Diagnostic du cancer, sélection de traitement et traitement |
EP2986326B1 (fr) | 2013-04-15 | 2018-09-05 | Cedars-Sinai Medical Center | Méthodes de détection de métastases cancéreuses |
AU2014290044B2 (en) | 2013-07-17 | 2020-10-29 | Foundation Medicine, Inc. | Methods of treating urothelial carcinomas |
WO2015081073A2 (fr) | 2013-11-26 | 2015-06-04 | The Brigham And Women's Hospital, Inc. | Compositions et procédés pour moduler une réponse immunitaire |
CA2931181C (fr) | 2013-12-09 | 2023-01-24 | Institut Curie | Procede pour la detection de l'inactivation de voie de recombinaison homologue (brca1/2) dans des tumeurs humaines |
CA2944903A1 (fr) | 2014-04-24 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Suppresseur de tumeur et biomarqueurs oncogenes predictifs de reponse a un inhibiteur de point de controle anti-immunitaire |
WO2015164605A1 (fr) | 2014-04-25 | 2015-10-29 | The Brigham And Women's Hospital, Inc. | Compositions et des procédés pour traiter des patients ayant des maladies à médiation immunitaire |
EP3180447B1 (fr) | 2014-08-15 | 2020-03-11 | Myriad Genetics, Inc. | Procédés et matériaux permettant d'évaluer une déficience de recombinaison homologue |
WO2016057367A1 (fr) | 2014-10-06 | 2016-04-14 | Dana-Farber Cancer Institute, Inc. | Biomarqueurs à base d'angiopoïétine -2 utilisés pour la prédiction de la réponse de point de contrôle anti-immunitaire |
WO2016057651A1 (fr) | 2014-10-09 | 2016-04-14 | Dana-Farber Cancer Institute, Inc. | Schéma posologique d'il-2 variables multiples pour le traitement de troubles immunitaires |
WO2016144673A1 (fr) | 2015-03-06 | 2016-09-15 | Dana-Farber Cancer Institute, Inc. | Biomarqueurs pd-l2 prédictifs de réponses d'inhibiteurs de la voie pd-1 dans les cancers oesophagogastriques |
EP3359692A4 (fr) | 2015-10-05 | 2019-05-01 | Cedars-Sinai Medical Center | Procédé de classification et de diagnostic du cancer |
JP2019509282A (ja) | 2016-02-29 | 2019-04-04 | ファウンデーション・メディシン・インコーポレイテッド | 癌の治療方法 |
JP6231709B1 (ja) | 2016-05-31 | 2017-11-15 | シスメックス株式会社 | 蛍光画像分析装置および分析方法 |
US20230183780A1 (en) | 2016-07-25 | 2023-06-15 | InVivo BioTech Services GmbH | Dna probes for in situ hybridization on chromosomes |
CA3034643A1 (fr) | 2016-09-20 | 2018-03-29 | Ellen Weisberg | Compositions et methodes pour l'identification, l'evaluation, la prevention et le traitement de la lma au moyen de biomarqueurs usp10 et de modulateurs |
WO2018226685A2 (fr) | 2017-06-06 | 2018-12-13 | Dana-Farber Cancer Institute, Inc. | Procédés de sensibilisation de cellules cancéreuses à une destruction médiée par des lymphocytes t par modulation de voies moléculaires |
JP7403965B2 (ja) * | 2019-03-29 | 2023-12-25 | シスメックス株式会社 | 蛍光画像分析装置及び蛍光画像分析方法 |
WO2022187374A1 (fr) | 2021-03-02 | 2022-09-09 | Dana-Farber Cancer Institute, Inc. | Procédés de traitement de troubles des globules rouges |
WO2022261183A2 (fr) | 2021-06-08 | 2022-12-15 | Dana-Farber Cancer Institute, Inc. | Compositions et procédés de traitement et/ou d'identification d'un agent pour le traitement de cancers intestinaux |
WO2023097119A2 (fr) | 2021-11-29 | 2023-06-01 | Dana-Farber Cancer Institute, Inc. | Méthodes et compositions pour moduler riok2 |
CN114240883B (zh) * | 2021-12-16 | 2022-06-07 | 易构智能科技(广州)有限公司 | 一种染色体图像处理方法及*** |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999290A (en) * | 1988-03-31 | 1991-03-12 | The Board Of Regents, The University Of Texas System | Detection of genomic abnormalities with unique aberrant gene transcripts |
US4874853A (en) * | 1988-04-18 | 1989-10-17 | City Of Hope | Synthetic oligonucleotides useful in diagnosis of chronic myelogenous leukemia |
WO1990005789A1 (fr) * | 1988-11-15 | 1990-05-31 | Yale University | Hybridation par suppression in situ et utilisations |
AU647741B2 (en) * | 1989-12-01 | 1994-03-31 | Regents Of The University Of California, The | Methods and compositions for chromosome-specific staining |
JP3645903B2 (ja) * | 1992-03-04 | 2005-05-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 比較ゲノムハイブリダイゼーション(cgh) |
US6590076B1 (en) * | 1999-04-02 | 2003-07-08 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
WO2000061814A1 (fr) * | 1999-04-09 | 2000-10-19 | The Regents Of The University Of California | Detection de changements dans le nombre de copies d'un chromosome, permettant de distinguer les naevi melanocytiques des melanomes malins |
JP2006094733A (ja) * | 2004-09-28 | 2006-04-13 | As One Corp | 癌の検出方法 |
JP2008048668A (ja) * | 2006-08-24 | 2008-03-06 | Yamaguchi Univ | Dnaコピー数多型を用いた癌発症体質の判定方法 |
-
1990
- 1990-07-13 AU AU58987/90A patent/AU647741B2/en not_active Expired
- 1990-07-16 NZ NZ234529A patent/NZ234529A/xx unknown
- 1990-07-19 KR KR1019900010947A patent/KR910012263A/ko not_active Application Discontinuation
- 1990-07-27 IE IE272790A patent/IE902727A1/en not_active IP Right Cessation
- 1990-07-27 IE IE20070380A patent/IE20070380A1/en unknown
- 1990-08-08 AT AT90308718T patent/ATE176281T1/de active
- 1990-08-08 DK DK98202403T patent/DK0885971T3/da active
- 1990-08-08 EP EP98202403A patent/EP0885971B1/fr not_active Revoked
- 1990-08-08 EP EP90308718A patent/EP0430402B2/fr not_active Expired - Lifetime
- 1990-08-08 DE DE1990632920 patent/DE69032920T4/de not_active Expired - Lifetime
- 1990-08-08 DE DE69034245T patent/DE69034245T2/de not_active Expired - Lifetime
- 1990-08-08 AT AT98202403T patent/ATE366323T1/de not_active IP Right Cessation
- 1990-08-21 JP JP22094690A patent/JP3771934B2/ja not_active Expired - Lifetime
-
2002
- 2002-11-20 JP JP2002337236A patent/JP2003199564A/ja not_active Withdrawn
-
2005
- 2005-07-15 JP JP2005207840A patent/JP4517152B2/ja not_active Expired - Lifetime
-
2008
- 2008-08-11 JP JP2008207383A patent/JP2008283989A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0885971B1 (fr) | 2007-07-04 |
EP0430402A3 (en) | 1991-09-11 |
IE20070380A1 (en) | 2007-06-27 |
NZ234529A (en) | 1993-12-23 |
JPH03224499A (ja) | 1991-10-03 |
ATE176281T1 (de) | 1999-02-15 |
EP0430402B1 (fr) | 1999-01-27 |
AU647741B2 (en) | 1994-03-31 |
JP2008283989A (ja) | 2008-11-27 |
EP0885971A3 (fr) | 1999-11-10 |
DE69034245D1 (de) | 2007-08-16 |
JP3771934B2 (ja) | 2006-05-10 |
DE69032920T4 (de) | 2009-11-05 |
EP0430402B2 (fr) | 2008-03-05 |
DE69032920D1 (de) | 1999-03-11 |
JP2005304508A (ja) | 2005-11-04 |
ATE366323T1 (de) | 2007-07-15 |
JP2003199564A (ja) | 2003-07-15 |
DE69032920T2 (de) | 1999-09-09 |
KR910012263A (ko) | 1991-08-07 |
AU5898790A (en) | 1991-06-06 |
EP0885971A2 (fr) | 1998-12-23 |
DE69032920T3 (de) | 2008-10-09 |
EP0430402A2 (fr) | 1991-06-05 |
JP4517152B2 (ja) | 2010-08-04 |
IE902727A1 (en) | 1991-06-05 |
DE69034245T2 (de) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0885971T3 (da) | Fremgangsmåde og præparat til kromosomspecifik farvning | |
DE69737398T2 (de) | Genetische Veränderungen im Zusammenhang mit Prostatakrebs | |
Roberts et al. | Amplification of the gli gene in childhood sarcomas | |
Meltzer et al. | Rapid generation of region specific probes by chromosome microdissection and their application | |
Merlo et al. | Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer | |
CA2231349C (fr) | Amplifications de la region chromosomale 20q13 servant d'indicateurs pour le pronostic du cancer du sein | |
Wiest et al. | Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene | |
US6060251A (en) | Amplification karyotyping | |
ATE407360T1 (de) | Verfahren und vorrichtung zur vorbereitung von gewebeproben für parallele analysen | |
Shimizu et al. | Universal fluorescent labeling (UFL) method for automated microsatellite analysis | |
Von Deimling et al. | A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas | |
Salk et al. | Passenger mutations as a marker of clonal cell lineages in emerging neoplasia | |
Kopp et al. | Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue | |
Jordan et al. | Advanced diagnostic methods in oral and maxillofacial pathology. Part I: molecular methods | |
Kucherlapati et al. | Mammalian chromosome identification in interspecific hybrid cells using “Hoechst 33258” | |
CA2021489A1 (fr) | Methodes et composes pour la coloration specifique de chromosomes | |
Cohen-Haguenauer et al. | Chromosomal assignment of two myosin alkali light-chain genes encoding the ventricular/slow skeletal muscle isoform and the atrial/fetal muscle isoform (MYL3, MYL4) | |
Moyret et al. | Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522 | |
Wong et al. | Identification of differentially expressed rna in human ovarian-carcinoma cells by arbitrarily primed pcr fingerprinting of total RNAS | |
Murthy et al. | New approaches to fluorescence in situ hybridization | |
Cherif et al. | Chromosome painting in acute monocytic leukemia | |
Chen et al. | Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections | |
Yeung et al. | New markers, D16FC1 and Tp12, differentiate between rat chromosomes 16 and 17 | |
Krebs et al. | The use of microsatellite instability in the distinction between synchronous endometrial and colonic adenocarcinomas | |
Shelling et al. | Molecular genetics of ovarian cancer |